BC

Bhargavi Chandrashekhar Nimkar

Active Director Designated Partner DIN 11905250
DIN 11905250 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhargavi Chandrashekhar Nimkar

Bhargavi Chandrashekhar Nimkar is a Designated Partner at Cgn 360 Pharma Llp (since 2026).

DIN 11905250
Primary Designation Designated Partner
First Appointment 21 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Aug 20262026Active

Board colleagues of Bhargavi Chandrashekhar Nimkar

NameDINCompanyDesignation
Asmita Chandrashekhar Nimkar08052133Cgn 360 Pharma LlpDesignated Partner
Chaitanya Chandrashekhar Nimkar07439563Cgn 360 Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cgn 360 Pharma Llp
Premium access

Shareholding and investment profile for Bhargavi Chandrashekhar Nimkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhargavi Chandrashekhar Nimkar

Bhargavi Chandrashekhar Nimkar currently holds 1 directorship: Cgn 360 Pharma Llp (Designated Partner, since 21 Aug 2026).

Bhargavi Chandrashekhar Nimkar was first appointed on 21 Aug 2026 as Designated Partner at Cgn 360 Pharma Llp.

The current boards of Bhargavi Chandrashekhar Nimkar's companies include Asmita Chandrashekhar Nimkar (Cgn 360 Pharma Llp), Chaitanya Chandrashekhar Nimkar (Cgn 360 Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available